Company profile
Intellia Therapeutics, Inc. Insider Trading
NTLAEvery SEC Form 4 insider trading filing for Intellia Therapeutics, Inc. (NTLA) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- In Vitro & In Vivo Diagnostic Substances
- CIK
- 0001652130
- Filings
- 104
- Insiders
- 18
- Last filing
- 2026-08-21
Activity summary
No insider transactions in the last 30 days. The most recent was on August 21, 2026, when John M Leonard sold 2,785 shares. 104 filings from 18 insiders are on record below.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. Intellia Therapeutics, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $1.6M.
90 day insight
Over the last 90 days, Intellia Therapeutics, Inc. insiders sold $136K across 2 transactions with no open-market purchases.
- Most active insider: John M Leonard with 2 transactions totaling $287K.
- Largest single sale: $251K by John M Leonard on Aug 20, 2026.
- 60% of recent sales were pre-scheduled 10b5-1 trades, typically less informative than open-market activity.
Activity skews bearish: sales outpace buys.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | John M Leonard | NTLA | Sale10b5 | 2,785 | $13.00 | $36K |
| Aug 20, 2026 | John M Leonard | NTLA | Sale10b5 | 19,890 | $12.60 | $251K |
| Jul 22, 2026 | Edward J Dulac III | NTLA | Sale | 8,111 | $11.25 | $91K |
| Jul 2, 2026 | Edward J Dulac III | NTLA | Sale10b5 | 4,677 | $18.00 | $84K |
| Jul 1, 2026 | Michael P Dube | NTLA | Sale | 2,641 | $16.78 | $44K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=NTLA" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.
Institutional Ownership
Top 13F-HR holders of Intellia Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →